NeuroLINCS Proteomics: Defining human-derived iPSC proteomes and protein signatures of pluripotency
Author(s)
Fraenkel, Ernest
DownloadPublished version (3.293Mb)
Publisher with Creative Commons License
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
<jats:title>Abstract</jats:title><jats:p>The National Institute of Health (NIH) Library of integrated network-based cellular signatures (LINCS) program is premised on the generation of a publicly available data resource of cell-based biochemical responses or “signatures” to genetic or environmental perturbations. NeuroLINCS uses human inducible pluripotent stem cells (hiPSCs), derived from patients and healthy controls, and differentiated into motor neuron cell cultures. This multi-laboratory effort strives to establish i) robust multi-omic workflows for hiPSC and differentiated neuronal cultures, ii) public annotated data sets and iii) relevant and targetable biological pathways of spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). Here, we focus on the proteomics and the quality of the developed workflow of hiPSC lines from 6 individuals, though epigenomics and transcriptomics data are also publicly available. Known and commonly used markers representing 73 proteins were reproducibly quantified with consistent expression levels across all hiPSC lines. Data quality assessments, data levels and metadata of all 6 genetically diverse human iPSCs analysed by DIA-MS are parsable and available as a high-quality resource to the public. </jats:p>
Date issued
2023-01-11Department
Massachusetts Institute of Technology. Department of Biological EngineeringJournal
Scientific Data
Publisher
Springer Science and Business Media LLC
Citation
Fraenkel, Ernest. 2023. "NeuroLINCS Proteomics: Defining human-derived iPSC proteomes and protein signatures of pluripotency." Scientific Data, 10 (1).
Version: Final published version